Martha Chekenya

3.0k total citations
41 papers, 2.1k citations indexed

About

Martha Chekenya is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Martha Chekenya has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 14 papers in Immunology and 13 papers in Oncology. Recurrent topics in Martha Chekenya's work include Glioma Diagnosis and Treatment (19 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (7 papers). Martha Chekenya is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (7 papers). Martha Chekenya collaborates with scholars based in Norway, Luxembourg and United States. Martha Chekenya's co-authors include Camilla Krakstad, Per Øyvind Enger, Jacques Zimmer, Justyna Kmiecik, Andrea Gras Navarro, Aurélie Poli, Per Øystein Sakariassen, Heike Immervoll, Andreas T. Björklund and Andreas Waha and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Martha Chekenya

41 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha Chekenya Norway 25 763 755 739 578 378 41 2.1k
Serena Pellegatta Italy 27 1.0k 1.3× 986 1.3× 748 1.0× 738 1.3× 513 1.4× 69 2.3k
Alexander Schulte Germany 24 951 1.2× 755 1.0× 689 0.9× 503 0.9× 505 1.3× 36 2.2k
Kirsten Hattermann Germany 25 909 1.2× 616 0.8× 671 0.9× 346 0.6× 271 0.7× 52 1.8k
Meizhang Li United States 22 861 1.1× 765 1.0× 549 0.7× 317 0.5× 433 1.1× 46 1.9k
Kyuson Yun United States 17 422 0.6× 1.2k 1.6× 529 0.7× 355 0.6× 304 0.8× 37 1.9k
Lene Uhrbom Sweden 29 678 0.9× 1.3k 1.8× 402 0.5× 966 1.7× 691 1.8× 56 2.4k
Konrad Gabrusiewicz United States 22 787 1.0× 880 1.2× 1.2k 1.6× 833 1.4× 495 1.3× 35 2.5k
Deric M. Park United States 26 543 0.7× 861 1.1× 311 0.4× 568 1.0× 490 1.3× 54 2.1k
Anna Golebiewska Luxembourg 23 480 0.6× 1.1k 1.5× 285 0.4× 559 1.0× 568 1.5× 42 2.1k
Joseph C. Murray United States 15 1.4k 1.9× 727 1.0× 957 1.3× 238 0.4× 321 0.8× 52 2.6k

Countries citing papers authored by Martha Chekenya

Since Specialization
Citations

This map shows the geographic impact of Martha Chekenya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Chekenya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Chekenya more than expected).

Fields of papers citing papers by Martha Chekenya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Chekenya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Chekenya. The network helps show where Martha Chekenya may publish in the future.

Co-authorship network of co-authors of Martha Chekenya

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Chekenya. A scholar is included among the top collaborators of Martha Chekenya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Chekenya. Martha Chekenya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goplen, Dorota, Saruar Alam, Judit Haász, et al.. (2023). Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI. Neuro-Oncology Advances. 5(1). vdad037–vdad037. 1 indexed citations
2.
Goplen, Dorota, Mohummad Aminur Rahman, Petter Brandal, et al.. (2023). BORTEM-17: A phase IB/II single arm, multicentre study investigating the efficacy of sequential bortezomib and temozolomide in recurrent GBM with unmethylated MGMT promoter—The results of an interim analysis.. Journal of Clinical Oncology. 41(16_suppl). 2019–2019. 1 indexed citations
3.
Rahman, Mohummad Aminur, et al.. (2021). P14.65 Survival in a consecutive series of 467 glioblastoma patients: impact of prognostic factors and recurrent treatment at two independent institutions. Neuro-Oncology. 23(Supplement_2). ii50–ii50. 1 indexed citations
4.
5.
Dominguez–Valentin, Mev, Andrea Gras Navarro, Mohummad Aminur Rahman, et al.. (2016). Identification of a Natural Killer Cell Receptor Allele That Prolongs Survival of Cytomegalovirus-Positive Glioblastoma Patients. Cancer Research. 76(18). 5326–5336. 26 indexed citations
6.
Navarro, Andrea Gras, Andreas T. Björklund, & Martha Chekenya. (2015). Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors. Frontiers in Immunology. 6. 202–202. 131 indexed citations
7.
Kmiecik, Justyna, Andrea Gras Navarro, Aurélie Poli, et al.. (2014). Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma. OncoImmunology. 3(1). e27185–e27185. 24 indexed citations
8.
Rygh, Cecilie Brekke, Jian Wang, Marte Thuen, et al.. (2014). Dynamic Contrast Enhanced MRI Detects Early Response to Adoptive NK Cellular Immunotherapy Targeting the NG2 Proteoglycan in a Rat Model of Glioblastoma. PLoS ONE. 9(9). e108414–e108414. 24 indexed citations
9.
10.
Kmiecik, Justyna, Jacques Zimmer, & Martha Chekenya. (2013). Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours. Journal of Neuro-Oncology. 116(1). 1–9. 52 indexed citations
11.
Moen, Ingrid, Jian Wang, Karl-Henning Kalland, et al.. (2012). Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. BMC Cancer. 12(1). 21–21. 17 indexed citations
12.
Wang, Jian, Agnete Svendsen, Justyna Kmiecik, et al.. (2011). Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma. PLoS ONE. 6(7). e23062–e23062. 87 indexed citations
13.
Poli, Aurélie, Nicolaas H. C. Brons, Wim Ammerlaan, et al.. (2010). Novel method for isolating untouched rat natural killer cells with higher purity compared with positive selection and fluorescence‐activated cell sorting. Immunology. 131(3). 386–394. 9 indexed citations
14.
Verhoeff, Joost J.C., Lukas J.A. Stalpers, Cornelis J.F. Van Noorden, et al.. (2009). Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation. Cancer Letters. 285(1). 39–45. 5 indexed citations
15.
Joo, Nam Eok, et al.. (2008). NG2, a novel proapoptotic receptor, opposes integrin α4 to mediate anoikis through PKCα-dependent suppression of FAK phosphorylation. Cell Death and Differentiation. 15(5). 899–907. 34 indexed citations
16.
Chekenya, Martha, Camilla Krakstad, Agnete Svendsen, et al.. (2008). The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene. 27(39). 5182–5194. 127 indexed citations
17.
Sakariassen, Per Øystein, Heike Immervoll, & Martha Chekenya. (2007). Cancer Stem Cells as Mediators of Treatment Resistance in Brain Tumors: Status and Controversies. Neoplasia. 9(11). 882–892. 123 indexed citations
18.
Chekenya, Martha & Heike Immervoll. (2006). NG2/HMP Proteoglycan as a Cancer Therapeutic Target. Humana Press eBooks. 361. 93–118. 7 indexed citations
19.
Chekenya, Martha, Per Øyvind Enger, Frits Thorsen, et al.. (2002). The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. Neuropathology and Applied Neurobiology. 28(5). 367–380. 61 indexed citations
20.
Chekenya, Martha & G. J. Pilkington. (2002). NG2 precursor cells in neoplasia: Functional, histogenesis and therapeutic implications for malignant brain tumours. Journal of Neurocytology. 31(6-7). 507 ppl=–521. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serena Pellegatta Breakdown of academic impact, for papers by Alexander Schulte Breakdown of academic impact, for papers by Kirsten Hattermann Breakdown of academic impact, for papers by Meizhang Li Breakdown of academic impact, for papers by Kyuson Yun Breakdown of academic impact, for papers by Lene Uhrbom Breakdown of academic impact, for papers by Konrad Gabrusiewicz Breakdown of academic impact, for papers by Deric M. Park Breakdown of academic impact, for papers by Anna Golebiewska Breakdown of academic impact, for papers by Joseph C. Murray
Rankless by CCL
2026